Nature’s Rx Issues Voluntary Nationwide Recall of Silver Bullet 10 Male Enhancement Capsules

By :

New Ebola Vaccine for Exposure Risk

Company Announcement Date: November 13, 2019 FDA 

Publish Date: November 13, 2019 

Product Type: Dietary Supplements Drugs 

Reason for Announcement: Due to unapproved active ingredient (sildenafil) 

Company Name :Nature’s Rx 

Brand Name: Silver Bullet 

Product Description: Male Enhancement Capsules 

Nature’s Rx is voluntarily recalling lot: 01251ZX1, Expiry Date: 11/2022 of Silver Bullet (10 Male Enhancement Capsules). This recall has been initiated after an FDA laboratory analysis found the product to contain undeclared sildenafil, the active ingredient in Viagra, which is a PDE-5 inhibitor. The undeclared PDE-5 inhibitor in the product may pose serious health risks to consumers with underlying medical issues. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, Nature’s Rx has not received any reports of adverse events related to this recall. The product, Silver Bullet (10 Male Enhancement Capsules), is used as a male enhancement nutritional supplement contained in blister foil sheets and packaged in small boxes containing 10 capsules with an expiry date: 11/2022 and lot number: 01251ZX1. Silver Bullet (10 Male Enhancement Capsules) was sold on an online website: Nature’s Rx is notifying its customers by replacement or refund and is arranging for return or replacement of all recalled products. Consumers that have Silver Bullet (10 Male Enhancement Capsules), which is being recalled should stop using and return ship or discard the product. Consumers with questions regarding this recall can contact Nature’s Rx by phone number or e-mail address 5 days of the week from 10 AM to 6 PM PST. 1-888-925-5551, email us at: or mail us at: 310 N Indian Hill Blvd Ste 600, Claremont, CA 91711 Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. #FDA #DrugRecall #Alert #NaturesRx #SilverBullet #Dietary #Supplements #Drugs

Rate UsDon’t love itNot greatGoodGreatLove itRate Us
Your opinion


FDA action against 14 companies for selling illegal cancer treatments


Patient Receiving Ocrelizumab may be associated with PML


Drug Alert : 60 drugs found substandard


Torrent Pharmaceuticals Limited - Recall of Losartan Potassium Tablets


After Fortis - Now Medanta hospital in Gurgaon charges massive Rs 16 lakh; 7-year-old dies


FDA Alert - Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and

© 2019 PHAF  || All rights reserved

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.